CME
50
5
T
44
2
UNP
52
2
CF
35
2
NVDA
63
4
MMM
32
2
HP
33
4
GM
77
2
A
48
4
APH
73
2
DIS
64
3
BBY
48
5
FOX
42
2
PRU
54
7
FTI
86
2
MCD
47
-15
REGN
71
6
MSFT
60
5
MET
50
3
AMP
72
3
CME
50
5
T
44
2
UNP
52
2
CF
35
2
NVDA
63
4
MMM
32
2
HP
33
4
GM
77
2
A
48
4
APH
73
2
DIS
64
3
BBY
48
5
FOX
42
2
PRU
54
7
FTI
86
2
MCD
47
-15
REGN
71
6
MSFT
60
5
MET
50
3
AMP
72
3
Financhill
Back

Foghorn Therapeutics 10K Form

Sell
50

FHTX
Foghorn Therapeutics

Last Price:
5.89
Seasonality Move:
15.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive FHTX News And Ratings

See the #1 stock for the next 7 days that we like better than FHTX

FHTX Financial Statistics

Sales & Book Value

Annual Sales: $34.16M
Cash Flow: $-27.58M
Price / Cash Flow: 0
Annual Sales: $-1.83
Price / Book: 0

Profitability

EPS (TTM): -2.34000
Net Income (TTM): $-98.43M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -28.67%

Foghorn Therapeutics Earnings Forecast

Key Foghorn Therapeutics Financial Ratios

  • The Research & Development expenses have been 321.15% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of FHTX is -288.17% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Foghorn Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: FHTX
Website: foghorntx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.11
Quick Ratio: 4.01

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

FHTX Technical Analysis vs Fundamental Analysis

Sell
50
Foghorn Therapeutics (FHTX) is a Sell

Is Foghorn Therapeutics a Buy or a Sell?